Methodological matters on an Alzheimer's dementia trial

is a double-blind randomized controlled study design sufficient to draw strong conclusions on treatment? Reply to Dr Mazza and colleagues

Mazza, M.
Capuano, A.
Bria, P.
Mazza, S.

^aDepartment of Psychiatry, and ^bDepartment of Neurology, Catholic University of Sacred Heart, Rome, Italy

Correspondence: Marianna Mazza, MD, PhD, Department of Psychiatry, Catholic University of Sacred Heart, Via Ugo De Carolis, 48 00136 Rome, Italy (tel.: 39 06 35348285; fax: 39 06 35501909; e-mail: [email protected], [email protected]).

Received 22 September 2006 Accepted 30 October 2006

European Journal of Neurology 14(9):p e12, September 2007.